CICCARELLI, CARMELA
 Distribuzione geografica
Continente #
EU - Europa 24
NA - Nord America 16
AS - Asia 4
Totale 44
Nazione #
US - Stati Uniti d'America 16
IE - Irlanda 11
IT - Italia 9
FR - Francia 4
VN - Vietnam 4
Totale 44
Città #
Dublin 11
Ashburn 8
Aquila 5
Columbus 4
Dong Ket 4
Boardman 2
L'aquila 2
L’Aquila 1
Rome 1
San Jose 1
Totale 39
Nome #
Biological rationale for targeting MEK/ERK pathways in anti-cancer therapy and to potentiate tumour responses to radiation, file e2188bfa-c23a-f28d-e053-d805fe0ac2bb 18
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population., file e2188bfb-7616-f28d-e053-d805fe0ac2bb 17
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines, file e2188bfa-c23c-f28d-e053-d805fe0ac2bb 3
Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines, file e2188bfa-df53-f28d-e053-d805fe0ac2bb 3
Granulosa cell-oocyte interactions, file e2188bf9-ade4-f28d-e053-d805fe0ac2bb 2
p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells, file e2188bf9-0dcb-f28d-e053-d805fe0ac2bb 1
Totale 44
Categoria #
all - tutte 112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 1 0 0 0 0 0 0 0 0
2020/20215 0 0 0 0 0 0 0 0 1 0 0 4
2021/20225 0 0 0 0 0 0 0 0 0 0 0 5
2022/202323 0 0 0 0 0 0 0 0 11 0 12 0
2023/20249 0 0 0 0 0 0 4 1 0 1 3 0
Totale 44